Literature DB >> 2907524

Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.

W M Wiersinga1, T Smit, R van der Gaag, L Koornneef.   

Abstract

The temporal relationship between the onset of Graves' ophthalmopathy and the onset of thyroidal Graves' disease was evaluated in 125 consecutive patients with Graves' ophthalmopathy. Thyroidal Graves' disease--past or present--was clinically evident in 99 patients (79%): hyperthyroidism in 3 cases. Thyroid disease preceded the eye disease in 37 patients, it occurred simultaneously with the eye disease in 39 patients, and it developed after the eye disease in 23 patients (in 16 cases within one yr after the onset of eye disease). The age at the onset of thyroid disease (38.7 +/- 12.9 yr) was lower than the age at the onset of ophthalmopathy (41.8 +/- 12.5 yr; p less than 0.001). Among the 26 clinically euthyroid patients (21%) laboratory evidence of thyroidal Graves' disease was found in 14 cases (11%): abnormal TRH test, n = 9; normal TRH test but abnormal T3-suppression test, n = 4; normal TRH and T3-suppression tests but positive thyroid stimulating antibodies, n = 1). We conclude that Graves' ophthalmopathy as a rule develops at a time when thyroid autoimmunity also exists. This strongly suggests a common factor in the pathogenesis of thyroidal and ocular expressions of Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907524     DOI: 10.1007/BF03350193

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

Review 1.  The pathogenesis of Graves' disease: an overview.

Authors:  R Volpé
Journal:  Clin Endocrinol Metab       Date:  1978-03

Review 2.  Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.

Authors:  D H Jacobson; C A Gorman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

3.  Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy.

Authors:  G T Gamblin; D G Harper; P Galentine; D R Buck; B Chernow; C Eil
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

4.  Ophthalmopathy of Graves' disease.

Authors:  C Gorman
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

5.  Changes in thyroid functions in patients with euthyroid Graves' disease.

Authors:  H Tamai; T Nakagawa; N Ohsako; O Fukino; H Takahashi; F Matsuzuka; K Kuma; S Nagataki
Journal:  J Clin Endocrinol Metab       Date:  1980-01       Impact factor: 5.958

6.  The triiodothyronine suppression test.

Authors:  G Burke
Journal:  Am J Med       Date:  1967-04       Impact factor: 4.965

7.  Ophthalmopathy associated with primary hypothyroidism.

Authors:  B E Brownlie; O A Newton; S P Singh
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08

8.  Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy.

Authors:  S Atkinson; M Holcombe; P Kendall-Taylor
Journal:  Lancet       Date:  1984-08-18       Impact factor: 79.321

9.  Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.

Authors:  C M Rotella; R Zonefrati; R Toccafondi; W A Valente; L D Kohn
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958

10.  Exophthalmos in autoimmune thyroid disease.

Authors:  N Amino; T Yuasa; Y Yabu; K Miyai; Y Kumahara
Journal:  J Clin Endocrinol Metab       Date:  1980-12       Impact factor: 5.958

View more
  35 in total

1.  Thyroid Eye Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.598

2.  Thyroid-associated orbitopathy.

Authors:  Adel H Alsuhaibani; Jeffrey A Nerad
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

3.  Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine.

Authors:  A Barth; P Probst; H Bürgi
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

4.  Hyperthyroid vs hypothyroid eye disease: the same severity and activity.

Authors:  M B Kashkouli; F Pakdel; V Kiavash; I Heidari; A Heirati; S Jam
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

Review 5.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

Review 6.  The evaluation and treatment of graves ophthalmopathy.

Authors:  Marius N Stan; James A Garrity; Rebecca S Bahn
Journal:  Med Clin North Am       Date:  2012-02-22       Impact factor: 5.456

Review 7.  Total thyroid ablation in Graves' orbitopathy.

Authors:  F Menconi; M Leo; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256

Review 8.  Risk factors for development or deterioration of Graves' ophthalmopathy.

Authors:  Marius N Stan; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

9.  HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients.

Authors:  R van der Gaag; W M Wiersinga; L Koornneef; M P Mourits; M F Prummel; A Berghout; R R de Vries; G M Schreuder; J D'Amaro
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

Review 10.  Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.

Authors:  Seethalakshmi Iyer; Rebecca Bahn
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.